Earlier this week, the Southeastern Medical Device Association announced several industry leading plenary and keynote speakers set for next month’s 2018 SEMDA Annual Medtech Conference in Greenville, South Carolina.

Mike Fisher, Director of Product Development, GCMI

Representing GCMI, and its Design and Development line of service, our Product Development Director, Mike Fisher will serve on a panel led by Paul Snyder, VP of Healthcare for Write2Market, and provide his insights on the impact of regulatory pathway decisions for marketing teams and budget requirements for medtech innovators. The discussion titled “Medtech Marketing and the Regulatory Minefield” will take place Friday, May 4 from 11:15 a.m. – 12:15 pm during SEMDA 2018 concurrent session #5

Mike and Paul will be joined by Allyson Bower-Willner a member of the Medtech Women at SEMDA board of directors. Together they will discuss how to avoid the many ways of going off-label or contra-indication that can spell disaster for companies of any size. How do medtech marketers ensure this does not happen to them while accomplishing their sales supporting mission effectively? Add it to your calendar!

Also, from the SEMDA press release: “Among the featured speakers announced today that have committed to present at the conference are Joe Lee, Executive Director of Life Sciences for JP Morgan; Andy Fish, Chief Strategy Officer of AdvaMed; and Denise Hines, North American Chair of the Health Information & Management Systems Society and current CEO of eHealth Services Group.  Also speaking will be Lee Burnes, Vice President of Global Research & Development at Halyard Health; and Jim Stefansic, Chief Executive Officer of Raiven Healthcare.

“Additional featured speakers are expected to be named shortly, and companies engaged in presenting to industry executives in the PitchRounds program, co-sponsored by SCRA, SCBIO and Eversheds Sutherland, will be announced within the week.”

For medtech innovators seeking to bring novel technologies and therapies to life- concept to cure, through design and development, preclinical testing and FDA approval all the way to commercialization- let’s connect! Contact Deepal Panchal or Andrew Stevenson to set up a meeting during SEMDA 2018! You can find the full conference agenda here.

You can also follow both GCMI on LinkedIn and Twitter.

GCMI LinkedIn

GCMI Twitter

Leave a Reply

Your email address will not be published.

Post comment